Rare Disease Data Trust
David is a veteran of the pharmaceutical industry during which he has spent the majority of his career working in the rare and ultra-rare disease marketplace. He has helped launch seven first-to-market, first-in-therapy rare and ultra-rare disease products, and eight biotech commercial startups. David has worked with some of the best-known names in pharmaceuticals, including Schering-Plough, Rhone Poulenc Rorer, Merck, Guilford, Pharmion, Viropharma, Shire Human Genetics, Aegerian, MTPA, and Novartis. David earned his BS in Business Marketing from Florida State University.
Rare Disease Data Trust
Rare Disease Data Trust partners with community provider health systems to execute patient-centric data monetization, executing lost rare disease patient analytics, through commercially sponsored (by bio-pharma) targeted searches for undiagnosed rare disease patients. Accelerating the discovery and diagnosis of targeted rare disease patients and rescuing them from their diagnostic odysseys.